Kabra Drugs Capacity Expansion: ₹200 Cr Investment
Kabra Drugs plans a ₹200 Crore pharmaceutical plant in Chhattisgarh. This expansion aims to boost manufacturing capacity and long-term growth.
- Value
- ₹200.0 Cr
ALFA Filings
Every announcement, straight from the exchange
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
2 announcements with these filters
Kabra Drugs plans a ₹200 Crore pharmaceutical plant in Chhattisgarh. This expansion aims to boost manufacturing capacity and long-term growth.
Kabra Drugs Limited announced strategic expansion into pharmaceutical manufacturing and AI-integrated defense technologies. Key initiatives include establishing an R&D facility at Cactus TECCI Park, Chennai, and obtaining a SCOMET license. The company also appointed Mr. Alagiamanavalan as an Independent Consultant for defense projects to drive diversification and long-term value creation.